Gastrointestinal Cancer News

A history of gum disease appeared associated with significantly elevated risks for two types of gastrointestinal cancer, according to prospective study results published in Gut.

Nintedanib appeared safe and effective for the treatment of advanced nonpancreatic neuroendocrine tumors, according to results of a phase 2 study published in Cancer.

Health care providers should begin offering routine HPV vaccination to children as young as age 9 years in order to increase rates of on-time administration, according to an updated American Cancer Society guideline.

A $5 million gift from Rosalie and Harold Rae Brown Charitable Foundation will fund a new venture within USC Norris Comprehensive Cancer Center designed to accelerate development of groundbreaking cancer treatments.

Use of renin-angiotensin-aldosterone system, or RAAS, antagonists such as ACE inhibitors or angiotensin receptor blockers was linked to reduced risk for colorectal cancer in the 3 years after an index colonoscopy with negative diagnosis.

As the director of The University of Arizona Cancer Center's Clinical Trials Office, and national expert in pancreatic and biliary cancers, Rachna Shroff, MD, shares the impact COVID-19 has had on our patients, clinical trials, and cancer care.

A liquid biopsy has shown promise for the early detection and staging of pancreatic ductal adenocarcinoma.

Black patients with esophageal cancer had a lower likelihood of receiving surgical intervention for resectable disease than their white counterparts, according to results of a retrospective study published in Journal of Gastrointestinal Surgery.

The FDA approved pembrolizumab for first-line treatment of patients with unresectable or metastatic microsatellite instability-high or mismatch repair-deficient colorectal cancer.

Increased rates of certain infections, such as influenza, gastroenteritis, hepatitis and pneumonia, appeared associated with an eventual cancer diagnosis, according to research published in Cancer Immunology Research.